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EDITORIAL
Educate is a word that was first used in the 16th century and derives 
from the Latin word educatus (to rear) and educere (to lead forth). 
In modern language, education refers to training of the mind, 
with acquisition of new knowledge and skills. In South Africa, 
education is a hot topic with important unresolved issues in 
basic and postgraduate education. People with diabetes require 
ongoing education as an integral part of their management. 
Knowledge acquired on the nature of the condition, factors 
that influence glycaemic control and the medication used is 
crucial to ensuring successful overall management. However, in 
busy clinics and resource-starved centres of health delivery, this 
aspect of care may easily be overlooked. Many diabetes clinics 
operate without the services of an educator and this is clearly 
not an optimal situation, if efforts to limit the morbidity and 
mortality associated with poor glycaemic control are serious. 
The dire situation with regard to diabetes education has been 
highlighted in a recent study on the status of programmes for 
diabetes education in both the private and the public sectors 
in South Africa.1 This survey reported that of 27 respondents, 
only 5 (18.5%) offered a structured programme for patients with 
diabetes and that most diabetes education was provided on an 
opportunistic ad hoc basis.1 The situation is made even more 
challenging by varying rates of literacy and cultural values and 
beliefs. Against this backdrop, it is encouraging to see studies on 
diabetes education in South Africa. 
In the current issue of JEMDSA, Muchiri and colleagues report on 
a study where diabetes education was evaluated over a 12-month 
period in the North West Province.  Although the intervention 
was weighted toward nutritional education, other aspects of 
diabetes were covered, and at 12 months diabetes knowledge 
was significantly better in the intervention group as compared 
to the control group. It is clear that many more studies relating 
to diabetes education and the optimal means of empowering 
people with diabetes to acquire effective self-management skills 
in our setting are required. 
Also in this issue, Ramkisson and colleagues report on levels of 
distress in patients attending both private and public health care 
facilities in KwaZulu-Natal. Any chronic disease may be associated 
with distress related to altered quality of life and disease-specific 
factors. Diabetes may be associated with many factors that 
induce distress, including the ongoing need for self-discipline in 
management, diet, adherence to exercise and anxiety regarding 
hypoglycaemia and chronic complications. Levels of distress 
may not be perceived when patients attend busy clinics, where 
high throughput of numbers may, of necessity, take precedence 
over quality holistic patient care. Ramkisson and colleagues 
found moderate to high levels of distress in 44% of the study 
sample and identified a number of factors associated with 
increased levels of distress. Identifying psychologic impediments 
to improved overall patient care is important and this study has 
identified factors that may be focused on in specific patient 
groups. 
Contemporary society abounds with technology and if this 
technology can be employed in a cost-effective manner to 
improve health outcomes, it should be made available on a 
wide scale. Glucose meters capable of accurate and reproducible 
ambulatory glucose measurement are one such technology 
and while it is generally accepted that self-monitoring of blood 
glucose (SMBG) is of clinical benefit in subjects with type 1 
diabetes and those with type 2 diabetes treated with insulin, the 
benefit in patients treated only with oral anti-hyperglycaemic 
therapy is less clear. A Cochrane analysis concluded that SMBG 
in patients with diabetes treated with oral agents provided 
a small benefit,2 whereas the PRISMA study showed overall 
benefit of SMBG.3 Pillay and Aldous report on the introduction of 
structured SMBG accompanied by education in a busy regional 
hospital in KwaZulu-Natal. Although the study sample was 
heterogeneous and included subjects with both type 1 and type 
2 diabetes, at 12 months, structured SMBG accompanied by 
education led to improvement in both groups and affirms the 
need for widespread access to meters and strips, particularly in 
insulin-treated patients. 
Finally, in the current issue of JEMDSA, Coetzee and colleagues 
describe three patients with cardiac tamponade associated with 
hypothyroidism. In South Africa, pericardial effusion is invariably 
equated with Mycobacterium tuberculosis infection and these 
cases illustrate the need to maintain vigilance for other diagnoses. 
The specific factors leading to such extensive pericardial fluid 
accumulation are intriguing as it is not uncommon to encounter 
patients with thyrotropin levels much higher than those reported 
in the 3 patients, yet without symptoms of pericardial disease. 
As the authors speculate, subclinical effusions are probably 
common and spontaneously resolve as the condition improves.
It is hoped that the readers enjoy this issue of JEMDSA and the 
reports provide a stimulus to extend the findings in other studies.
Dr F J Pirie, guest editor 
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